A federal judge has ruled that Becton Dickinson and Co. did not infringe two Abbott Laboratories patents for blood-glucose test strips, but infringement claims regarding two other patents can move forward.
An appeals court has affirmed a decision not to dismiss an Employee Retirement Income Securities Act class action against health care company Baxter International Inc.
A drug distribution company has filed a proposed antitrust class action against Biovail Corp. and GlaxoSmithKline Corp. alleging that the two companies filed frivolous patent lawsuits to keep a generic version of antidepressant Wellbutrin XL from reaching the market.
Drugmaker Pfizer Inc. scored a victory in ongoing multidistrict litigation over Viagra when a judge decided Wednesday to bar the testimony of most of the plaintiffs' nominated causation experts on the issue of a link between the blockbuster impotence drug and eye damage.
Medical device maker ev3 has finalized an agreement that would give $11.7 million to the University of California to settle a dispute over patents related to the treatment of brain aneurysms, the university said.
As the Federal Circuit gears up to hear en banc a case over whether to limit patent eligibility for business methods and other processes, parties in the financial, technology and health industries are coming down on opposite sides of the dispute.
Since a federal judge struck down a set of highly controversial rules crafted by the U.S. Patent and Trademark Office earlier this month, patent lawyers have been speculating what effect the decision will have on yet another set of hotly contested rules still in the patent office pipeline: the so-called IDS rules.
The U.S. Food and Drug Administration has withdrawn a set of good manufacturing practice regulations for the pharmaceuticals industry after the public comment period prompted a barrage of objections.
A federal judge has shot down summary judgment requests from both sides in an ongoing patent infringement dispute between Applera Corp.'s Applied Biosystems Group and rival Illumina Inc.
In the wake of the Vytorin controversy, a proposed class action is accusing Merck & Co. and its leaders of deliberately trying to mislead shareholders over the cholesterol drug in order to pump up the company's stock.
The U.S. Supreme Court has snuffed Alphapharm Pty Ltd.'s hopes of soon launching a generic version of Takeda Pharmaceutical Co.'s blockbuster diabetes drug Actos, refusing last week to review an appeals court decision upholding Takeda's patent infringement claims.
The U.S. Food and Drug Administration's finding this year that Teva Parenteral Medicines Inc. would not have to renounce its exclusivity window for its generic granisetron cast light on certain holes in the Medicare Modernization Act of 2003 that could allow generic-drug makers to continue “parking” their exclusivity past the forfeiture deadline the legislation attempted to set.
A federal judge in charge of multidistrict litigation over Novartis Pharmaceuticals Corp.'s bone cancer drugs has dismissed the cases of three Michigan plaintiffs who had relied on a split U.S. Supreme Court decision to bolster their claims.
Novartis Pharmaceuticals Corp. will make Zelnorm, its drug for irritable bowel syndrome with constipation, available to patients only in emergency situations, the U.S. Food and Drug Administration announced Wednesday.
A recent study has revealed that large doses of Pfizer Inc.’s pain medication Celebrex may increase the risk of cardiovascular events in patients, cautioning doctors against prescribing high doses of the drug to patients with a history of such events.
A federal judge tossed the last of Invacare Corp.'s antitrust claims against Respironics Inc. on Monday, finding the medical-device-maker's donation of its products and other goods and services to sleep labs and suppliers did not constitute exclusive agreements with the recipients.
Pharmaceutical company Sepracor Inc. and the University of Massachusetts have filed suit against Sandoz Inc., claiming the generic-drug maker’s proposed version of allergy treatment Clarinex infringes two of their patents.
Japanese drugmaker Otsuka Pharmaceutical Co. Ltd. has filed a patent infringement suit against Teva Pharmaceuticals USA Inc. and its Israeli parent company Teva Pharmaceutical Industries Ltd. over the anti-psychotic drug Abilify.
Safety-syringe-maker Retractable Technologies Inc. wasted no time filing a new suit against medical technology giant Becton Dickinson and Co. after the U.S. Patent and Trademark Office issued a patent on Tuesday that the plaintiff claims is infringed by Becton Dickinson's retractable syringes.
A judge has refused Wyeth's attempts to win an interlocutory appeal of decisions regarding expert testimony and the statute of limitations in a case that is part of the multidistrict litigation alleging that the company's hormone replacement treatments caused breast cancer.